Lucia Qian
Director/Board Member at Affamed Therapeutics (Us), Inc.
Profile
Lucia Qian is currently a Director at Affamed Therapeutics (Us), Inc. Previously, she worked as a Director of Marketing & Investor Relations at China Nepstar Chain Drugstore Ltd.
Lucia Qian active positions
Companies | Position | Start |
---|---|---|
Affamed Therapeutics (Us), Inc.
Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Part of AffaMed Therapeutics, Affamed Therapeutics (US), Inc. is a clinical stage biopharmaceutical company based in New York, NY. The company focuses on developing and commercializing pharmaceutical, digital, and surgical products to address critical unmet medical needs in ophthalmological, neurological, and psychiatric disorders for patients worldwide. The CEO of the company is Dayao Zhao. | Director/Board Member | - |
Former positions of Lucia Qian
Companies | Position | End |
---|---|---|
CHINA NEPSTAR CHAIN DRUGSTORE LTD.(ADR) | Investor Relations Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
China Nepstar Chain Drugstore Ltd.
China Nepstar Chain Drugstore Ltd. Drugstore ChainsRetail Trade China Nepstar Chain Drugstore Ltd. operates as a holding company, which is engaged in the operation of retail pharmacies. It provides pharmacy services and sells prescription drugs, over the counter drugs, nutritional supplements, herbal products, personal and family care products, and convenience products. The company was founded by Si Min Zhang in June 1995 and is headquartered in Shenzhen, China. | Retail Trade |
Affamed Therapeutics (Us), Inc.
Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Part of AffaMed Therapeutics, Affamed Therapeutics (US), Inc. is a clinical stage biopharmaceutical company based in New York, NY. The company focuses on developing and commercializing pharmaceutical, digital, and surgical products to address critical unmet medical needs in ophthalmological, neurological, and psychiatric disorders for patients worldwide. The CEO of the company is Dayao Zhao. | Health Technology |
- Stock Market
- Insiders
- Lucia Qian